Grade My Investments
Home › Free Stock Grades › INGN

Inogen, Inc. (INGN) Stock Grade

INGN · Healthcare

C
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$147.3M
P/E Ratio
—
Revenue Growth (YoY)
+3.9%
Net Margin
-6.5%
Return on Equity
—
Dividend Yield
None

About Inogen, Inc.'s fundamentals

Inogen is a small-cap medical device company with a market capitalization of $147.3 million that generated modest revenue growth of 3.9% year-over-year. However, the company is currently unprofitable, operating at a net margin of -6.5%, and reported a net loss in its latest annual statement. The company does not pay a dividend, and standard valuation metrics like P/E ratio and return on equity are not meaningful given the negative profitability. Investors should note that the company's financial performance reflects operational challenges despite its presence in the healthcare devices sector.

Track INGN free — no credit card required. Live grade + monthly AI report →